New lens aims to sharpen sight after cataract removal

NCT ID NCT07650201

Not yet recruiting Disease control Sponsor: Kowa Research Institute, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new artificial lens, called an intraocular lens (IOL), placed in the eye during cataract surgery. The lens is designed to replace the eye's natural lens and help restore vision. Researchers will measure how clearly participants see one year after surgery and check for any side effects. The study includes adults who need cataract surgery and aims to confirm the lens is safe and works well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: KI-362-US1 (YP2.2VM) intraocular lens (IOL)
What this could lead to: If successful, this lens could offer a safe and effective option for restoring clear vision after cataract surgery.
What could go wrong: This is a single-arm study without a comparison group, so results may not prove superiority over existing lenses. Risks include typical post-surgery complications like infection or lens dislocation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA, POSTCATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aphakia, Postcataract cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APHAKIA, POSTCATARACT

More trials for these conditions

Other studies related to the condition(s) this trial covers.